ImmunomeÂ Inc (IMNM) Financials

$26.76

$-0.40 (-1.47%)

As on 04-Sep-2026 16:08EDT

Market cap

$3,039 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

5.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	6.94	9.04	14.02	6.63	--
Cost of Revenue	50.72	2.96	2.10	0.73	0.63	0.76
Gross Profit	-50.72	3.99	9.04	14.02	-0.63	-0.76
Operating Expenses	220.52	218.10	314.84	123.55	36.90	25.20
Operating Profit (EBIT)	-270.47	-214.11	-305.80	-109.53	-36.90	-25.20
Other Income	--	--	--	--	0.01	--
Profit before Tax	-254.32	-212.39	-292.96	-106.81	-36.90	-24.71
Provision for Tax	--	--	-292.96	0.56	0.62	-0.24
Profit after Tax (Net Income)	-254.32	-212.39	-292.96	-106.81	-36.90	-24.71
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-37.52	-24.71

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	525.08	634.34	181.17	119.88	16.65	48.19
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	4.59	3.86	4.77	6.83	0.06	0.01
Current Liabilities	35.71	44.99	54.31	21.83	7.33	9.73
Total Liabilities	601.10	683.19	240.24	148.54	24.05	57.93

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	26.94	22.41	18.90	3.84	1.40	1.29
Current Assets	538.45	660.78	221.34	144.70	22.65	56.64
Total Assets	601.10	683.19	240.24	148.54	24.05	57.93
Total Debt*	4.59	3.86	4.83	1.65	0.29	0.32
Net Current Assets	502.74	615.79	167.03	122.87	15.32	46.91

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-190.92	-110.79	-7.57	-28.69	-18.23
Cash Flow from Investing Activities	--	60.80	-85.06	-30.48	-0.25	-0.08
Cash from Financing Activities	--	640.36	240.53	116.41	0.03	27.77
Net Cash Inflow / Outflow	--	--	--	--	-28.91	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.57	-2.43	-4.67	-4.87	-3.04	-2.07
Cash EPS ($)	-2.49	-2.40	-4.64	-4.83	-2.99	-2.01
Adjusted Book Value ($)	4.63	7.26	2.89	5.46	1.37	4.04
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.19	-1.77	-0.34	-2.37	-1.53
Free Cash Flow per Share ($)	--	-2.30	-2.62	-0.38	-2.39	-1.53

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-51.54	-190.53	-154.26	-112.75	-54.63
ROE (%)	-43.87	-52.09	-194.63	-156.45	-113.81	-55.20
ROA (%)	-55.27	-46.00	-150.71	-123.77	-90.02	-48.24
EBIT Margin (%)	--	-3,059.99	-1,697.33	-204.94	-556.68	--
Net Margin (%)	--	-3,059.99	-3,240.38	-761.92	-556.33	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-0.23	-0.36	1.12	--	--
EBIT Growth (%)	-37.88	-38.41	-434.17	22.13	-49.35	-101.46
Net Profit Growth (%)	-19.75	27.50	-174.29	-189.48	-49.31	-44.34
EPS Growth (%)	16.54	0.48	0.04	-0.60	-0.47	-0.23
Book Value Growth (%)	49.79	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-8.83	-2.27	-2.20	-0.73	-6.26
Price / Book Value	5.91	2.96	3.68	1.96	1.61	3.21
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.72	-5.86	-3.00	-3.51	-0.19	-4.42
Close Price ($)	21.19	21.48	10.62	10.70	2.21	12.96
High Price ($)	27.65	25.30	30.96	11.25	14.23	63.78
Low Price ($)	7.96	5.15	8.97	2.20	2.09	9.50
Market Cap ($ Cr)	3,039.34	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.03	0.01	0.02	0.01
Short term debt to equity ratio	--	--	0.00	0.00	0.01	0.01
Current Ratio	15.08	14.69	4.08	6.63	3.09	5.82
Quick Ratio	15.08	--	--	--	3.21	6.27
Interest Coverage	--	--	--	--	-7,378.20	-2,470.10

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	2.06	12.78	--
Asset Turnover	--	0.02	0.05	0.16	0.16	--
Receivable days	--	--	11.68	14.80	142.17	--
Inventory Days	--	--	--	-424.95	-1,493.13	-1,260.72
Payable days	--	1,083.27	1,520.43	1,432.65	1,585.16	1,031.41
Cash Conversion Cycle	--	--	--	-1,842.81	-2,936.12	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.